ea0081ep36 | Adrenal and Cardiovascular Endocrinology | ECE2022
Hashimoto Naoko
, Kono Satomi
, Kono Takashi
, Akira Shimatsu
, Pedroncelli Alberto
, Tanaka Tomoaki
Context: Osilodrostat (Osi), a potent inhibitor of 11β-hydroxylase, blocks the conversion of 11-deoxycortisol to cortisol and improves hypercortisolism in patients with Cushings syndrome (CS). Here, we report a study evaluating the efficacy of Osi in five non-Cushings disease (CD) CS patients treated with Osi in Japan.Subjects and Results: Five patients with non-CD CS were treated with Osi at Chiba University [primary disease breakdown: ...